🚀 VC round data is live in beta, check it out!
Viveo Valuation Multiples
Discover revenue and EBITDA valuation multiples for Viveo and similar public comparables like Mercator Medical, Farminveste, Meditera, Laxmi Dental and more.
Viveo Overview
About Viveo
CM Hospitalar SA is a distributor of hospital materials and medicines in the Brazilian market.
Founded
1996
HQ
Employees
N/A
Sectors
Financials (LTM)
EV
$715M
Viveo Financials
Viveo reported last 12-month revenue of $2B and EBITDA of $157M.
In the same LTM period, Viveo generated $157M in EBITDA and $14M in net income.
Revenue (LTM)
Viveo P&L
In the most recent fiscal year, Viveo reported revenue of $2B and EBITDA of ($79M).
Viveo expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $2B | XXX | $2B | XXX | XXX | XXX |
| Gross Profit | — | XXX | $248M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 11% | XXX | XXX | XXX |
| EBITDA | $157M | XXX | ($79M) | XXX | XXX | XXX |
| EBITDA Margin | 7% | XXX | (4%) | XXX | XXX | XXX |
| EBIT Margin | 5% | XXX | (1%) | XXX | XXX | XXX |
| Net Profit | $14M | XXX | ($269M) | XXX | XXX | XXX |
| Net Margin | 1% | XXX | (12%) | XXX | XXX | XXX |
| Net Debt | — | — | $632M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Viveo Stock Performance
Viveo has current market cap of $95M, and enterprise value of $715M.
Market Cap Evolution
Viveo's stock price is $0.30.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $715M | $95M | (0.6%) | XXX | XXX | XXX | $-0.85 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialViveo Valuation Multiples
Viveo trades at 0.3x EV/Revenue multiple, and 4.5x EV/EBITDA.
EV / Revenue (LTM)
Viveo Financial Valuation Multiples
As of March 7, 2026, Viveo has market cap of $95M and EV of $715M.
Equity research analysts estimate Viveo's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Viveo has a P/E ratio of 6.7x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $95M | XXX | $95M | XXX | XXX | XXX |
| EV (current) | $715M | XXX | $715M | XXX | XXX | XXX |
| EV/Revenue | 0.3x | XXX | 0.3x | XXX | XXX | XXX |
| EV/EBITDA | 4.5x | XXX | (9.0x) | XXX | XXX | XXX |
| EV/EBIT | 7.4x | XXX | (22.5x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 2.9x | XXX | XXX | XXX |
| P/E | 6.7x | XXX | (0.4x) | XXX | XXX | XXX |
| EV/FCF | (49.7x) | XXX | (24.9x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Viveo Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Viveo Margins & Growth Rates
Viveo's revenue in the last 12 month grew by 6%.
Viveo's rule of 40 is 13% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Viveo's rule of X is 21% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Viveo Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | (3%) | XXX | XXX | XXX |
| EBITDA Margin | 7% | XXX | (4%) | XXX | XXX | XXX |
| EBITDA Growth | (9%) | XXX | (303%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 13% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 21% | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 4% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 9% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 13% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Viveo Public Comps
See public comps and valuation multiples for other Medical Supplies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Mercator Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Farminveste | XXX | XXX | XXX | XXX | XXX | XXX |
| Meditera | XXX | XXX | XXX | XXX | XXX | XXX |
| Laxmi Dental | XXX | XXX | XXX | XXX | XXX | XXX |
| ADDvise Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Viveo M&A Activity
Viveo acquired XXX companies to date.
Last acquisition by Viveo was on XXXXXXXX, XXXXX. Viveo acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Viveo
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialViveo Investment Activity
Viveo invested in XXX companies to date.
Viveo made its latest investment on XXXXXXXX, XXXXX. Viveo invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Viveo
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Viveo
| When was Viveo founded? | Viveo was founded in 1996. |
| Where is Viveo headquartered? | Viveo is headquartered in Brazil. |
| Is Viveo publicly listed? | Yes, Viveo is a public company listed on B3. |
| What is the stock symbol of Viveo? | Viveo trades under VVEO3 ticker. |
| When did Viveo go public? | Viveo went public in 2021. |
| Who are competitors of Viveo? | Viveo main competitors are Mercator Medical, Farminveste, Meditera, Laxmi Dental. |
| What is the current market cap of Viveo? | Viveo's current market cap is $95M. |
| What is the current revenue of Viveo? | Viveo's last 12 months revenue is $2B. |
| What is the current revenue growth of Viveo? | Viveo revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Viveo? | Current revenue multiple of Viveo is 0.3x. |
| Is Viveo profitable? | Yes, Viveo is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Viveo? | Viveo's last 12 months EBITDA is $157M. |
| What is Viveo's EBITDA margin? | Viveo's last 12 months EBITDA margin is 7%. |
| What is the current EV/EBITDA multiple of Viveo? | Current EBITDA multiple of Viveo is 4.5x. |
| What is the current FCF of Viveo? | Viveo's last 12 months FCF is ($14M). |
| What is Viveo's FCF margin? | Viveo's last 12 months FCF margin is (1%). |
| What is the current EV/FCF multiple of Viveo? | Current FCF multiple of Viveo is (49.7x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.